Similar articles

• Norgestimate: overview of a monophasic formulation.

  Anderson FD, Gillmer MD. Anderson FD, et al. Int J Fertil Menopausal Stud. 1993;38 Suppl 3:126-32. Int J Fertil Menopausal Stud. 1993. PMID: 8260971 Review. No abstract available.
• Clinical experience with a new norgestimate-containing oral contraceptive.

  Huber J. Huber J. Int J Fertil. 1992;37 Suppl 1:47-53. Int J Fertil. 1992. PMID: 1347520 Clinical Trial.
• [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].

  [No authors listed] [No authors listed] Gynakologe. 1994 Apr;27(2 Suppl):1-12. Gynakologe. 1994. PMID: 9131064 German. No abstract available.
• Effects on blood lipid and androgen levels of two triphasic oral contraceptives.

  Janaud A, Rouffy J, Upmalis D, Dain MP. Janaud A, et al. Int J Fertil Menopausal Stud. 1993;38 Suppl 3:114-6. Int J Fertil Menopausal Stud. 1993. PMID: 8260968 Clinical Trial. No abstract available.
• The European experience: an overview.

  Gillmer MD. Gillmer MD. Int J Fertil. 1992;37 Suppl 1:36-46. Int J Fertil. 1992. PMID: 1347519 Review. No abstract available.